Nemaura Medical Announces Order for 200 | 合法醫療器材資訊網

2021年5月5日—UserfeedbackhasbeenextremelypositiveduetothefactthatsugarBEAT®istheonlydaily-wearglucosemonitoringdeviceintheworldthat ...

Based on the success of the soft launch in the U.K., the Company is advancing discussions for joint launches in Germany, Saudi Arabia and UAE

Loughborough, England, May 05, 2021 (GLOBE NEWSWIRE) -- Nemaura Medical, Inc. (NASDAQ: NMRD) (“Nemaura” or the “Company”), a medical technology company focused on developing and commercializing non-invasive wearable diagnostic devices and supporting personalized lifestyle coaching programs, today announced receipt of a purchase order for 5,000 sugarBEAT® transmitters and 200,000 sugarBEAT® sensors from its U.K. licensee, DB Ethitronix Ltd, with an additional rolling monthly purchase order forecast for the next 24 months of 15,000 transmitters and 2.1 million sensors, with an option to increase volumes based on customer response.

This order follows positive feedback from DB Ethitronix’s soft launch of the sug...